Literature DB >> 23430810

Long-Term Follow-up of a Successfully Treated Case of Congenital Pyridoxine-Dependent Epilepsy.

Malcolm Proudfoot1, Philip Jardine, Agne Straukiene, Rupert Noad, Andrew Parrish, Sian Ellard, Stuart Weatherby.   

Abstract

Autosomal recessive disorders affecting pyridoxine (vitamin B6) metabolism are a rare but well-recognized cause of neonatal seizures. Antiquitin deficiency, caused by mutations in ALDH7A1, is a disorder of the lysine degradation pathway causing accumulation of an intermediate that complexes with pyridoxal phosphate. Reports of long-term follow-up of neonatal pyridoxine-dependent seizures (PDS) remain scarce and prognostic information is varied. We report a case of PDS in a 47-year-old lady who originally presented shortly after birth in 1964. Pyridoxine replacement was successful and diagnostic confirmation was obtained later in life, initially by biochemical analysis of serum pipecolic acid. Subsequently we organized genetic analysis of ALDH7A1, which revealed compound heterozygous mutations. To our knowledge, this represents the longest duration of follow-up published to date.

Entities:  

Year:  2013        PMID: 23430810      PMCID: PMC3755577          DOI: 10.1007/8904_2012_210

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  25 in total

1.  Epidemiology of pyridoxine dependent seizures in the Netherlands.

Authors:  J V Been; L A Bok; P Andriessen; W O Renier
Journal:  Arch Dis Child       Date:  2005-09-13       Impact factor: 3.791

2.  Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene.

Authors:  Barbara Plecko; Karl Paul; Eduard Paschke; Sylvia Stoeckler-Ipsiroglu; Eduard Struys; Cornelis Jakobs; Hans Hartmann; Thomas Luecke; Matteo di Capua; Christoph Korenke; Christiane Hikel; Elke Reutershahn; Michael Freilinger; Fritz Baumeister; Friedrich Bosch; Wolfgang Erwa
Journal:  Hum Mutat       Date:  2007-01       Impact factor: 4.878

3.  Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials.

Authors:  Clara D M van Karnebeek; Hans Hartmann; Sravan Jaggumantri; Levinus A Bok; Barb Cheng; Mary Connolly; Curtis R Coughlin; Anibh M Das; Sidney M Gospe; Cornelis Jakobs; Johanna H van der Lee; Saadet Mercimek-Mahmutoglu; Uta Meyer; Eduard Struys; Graham Sinclair; Johan Van Hove; Jean-Paul Collet; Barbara R Plecko; Sylvia Stockler
Journal:  Mol Genet Metab       Date:  2012-09-10       Impact factor: 4.797

4.  Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency.

Authors:  Bernhard Schmitt; Matthias Baumgartner; Philippa B Mills; Peter T Clayton; Cornelis Jakobs; Elmar Keller; Gabriele Wohlrab
Journal:  Dev Med Child Neurol       Date:  2010-03-29       Impact factor: 5.449

5.  Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient.

Authors:  P Baxter; P Griffiths; T Kelly; D Gardner-Medwin
Journal:  Dev Med Child Neurol       Date:  1996-11       Impact factor: 5.449

6.  Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic semialdehyde levels.

Authors:  Levinus A Bok; Eduard Struys; Michel A A P Willemsen; Jasper V Been; Cornelis Jakobs
Journal:  Arch Dis Child       Date:  2006-11-06       Impact factor: 3.791

7.  Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy.

Authors:  R S McLachlan; W F Brown
Journal:  Can J Neurol Sci       Date:  1995-02       Impact factor: 2.104

8.  Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants.

Authors:  F Goutières; J Aicardi
Journal:  Ann Neurol       Date:  1985-02       Impact factor: 10.422

9.  Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency).

Authors:  Philippa B Mills; Emma J Footitt; Kevin A Mills; Karin Tuschl; Sarah Aylett; Sophia Varadkar; Cheryl Hemingway; Neil Marlow; Janet Rennie; Peter Baxter; Olivier Dulac; Rima Nabbout; William J Craigen; Bernhard Schmitt; François Feillet; Ernst Christensen; Pascale De Lonlay; Mike G Pike; M Imelda Hughes; Eduard A Struys; Cornelis Jakobs; Sameer M Zuberi; Peter T Clayton
Journal:  Brain       Date:  2010-06-16       Impact factor: 13.501

10.  An intriguing "silent" mutation and a founder effect in antiquitin (ALDH7A1).

Authors:  Gajja S Salomons; Levinus A Bok; Eduard A Struys; Lorna Landegge Pope; Patricia S Darmin; Philippa B Mills; Peter T Clayton; Michèl A Willemsen; Cornelis Jakobs
Journal:  Ann Neurol       Date:  2007-10       Impact factor: 10.422

View more
  1 in total

1.  Pyridoxine-dependent epilepsy: report on three families with neuropathology.

Authors:  Florent Marguet; Hager Barakizou; Abdellah Tebani; Lenaig Abily-Donval; Stéphanie Torre; Fethi Bayoudh; Sami Jebnoun; Marie Brasseur-Daudruy; Stéphane Marret; Annie Laquerriere; Soumeya Bekri
Journal:  Metab Brain Dis       Date:  2016-07-20       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.